A randomized, open-label, 2-period, crossover pharmacokinetic study to evaluate, after single and multiple doses, whether esomeprazole magnesium (Nexium) 40 mg opened capsule in water, administered through a nasogastric tube, is bioequivalent to an intact 40 mg capsule, administered orally, in healthy subjects

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].